Relative to control (vehicle treatment), tumor sizes in mice treated with RAD51 inhibitor, cisplatin and combination of RAD51 inhibitor and cisplatin were reduced by 30%, 59% and 71%, respectively (p < 0.04) (Figure 6). This evidence concerns the gene RAD51 and neoplasm.